362 related articles for article (PubMed ID: 2504855)
1. Plasma lipoprotein changes after treatment with pravastatin and gemfibrozil in patients with familial hypercholesterolemia.
Franceschini G; Sirtori M; Vaccarino V; Gianfranceschi G; Chiesa G; Sirtori CR
J Lab Clin Med; 1989 Sep; 114(3):250-9. PubMed ID: 2504855
[TBL] [Abstract][Full Text] [Related]
2. Pravastatin vs gemfibrozil in the treatment of primary hypercholesterolemia. The Italian Multicenter Pravastatin Study I.
Crepaldi G; Baggio G; Arca M; Avellone G; Avogaro P; Bittolo Bon G; Bompiani GD; Capurso A; Cattin L; D'Alŏ G
Arch Intern Med; 1991 Jan; 151(1):146-52. PubMed ID: 1898694
[TBL] [Abstract][Full Text] [Related]
3. Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.
Illingworth DR; Bacon S
Arteriosclerosis; 1989; 9(1 Suppl):I121-34. PubMed ID: 2492189
[TBL] [Abstract][Full Text] [Related]
4. [Pravastatin, cholestyramine and gemfibrozil in long-term therapy of primary hypercholesterolemia. An open randomized comparative study].
Ditschuneit HH; Dreyer M; Dammann HG; Ditschuneit H
Med Klin (Munich); 1991 Mar; 86(3):142-8. PubMed ID: 1903497
[TBL] [Abstract][Full Text] [Related]
5. Effects of CS-514, a new inhibitor of HMG CoA reductase, on plasma lipids, lipoproteins and apoproteins in patients with primary hypercholesterolemia.
Kazumi T; Yoshino G; Kasama T; Iwatani I; Iwai M; Morita S; Baba S
Horm Metab Res; 1986 Sep; 18(9):654-5. PubMed ID: 3096862
[No Abstract] [Full Text] [Related]
6. Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins.
Lupien PJ; Brun D; Gagné C; Moorjani S; Bielman P; Julien P
Can J Cardiol; 1991; 7(1):27-33. PubMed ID: 2025787
[TBL] [Abstract][Full Text] [Related]
7. [Effect of pravastatin on hepatic cholesterol metabolism].
Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
Fortschr Med; 1991 Mar; 109(8):189-94. PubMed ID: 1905265
[TBL] [Abstract][Full Text] [Related]
8. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
Superko HR; Garrett BC; King SB; Momary KM; Chronos NA; Wood PD
Am J Cardiol; 2009 Feb; 103(3):387-92. PubMed ID: 19166694
[TBL] [Abstract][Full Text] [Related]
9. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
[TBL] [Abstract][Full Text] [Related]
10. [Pravastatin increases the activity pf the LDL receptors in lymphocytes of individuals with heterozygous familial hypercholesterolemia].
Alvarez-Sala LA; Mata P; Blázquez E; Garrido JA; Ordovás JM; Rubio MJ; de Oya M
Rev Clin Esp; 1997 May; 197(5):317-22. PubMed ID: 9280964
[TBL] [Abstract][Full Text] [Related]
11. Effects of lovastatin and gemfibrozil on high-density lipoprotein subfraction density and composition in patients with familial hypercholesterolemia.
Tilly-Kiesi M; Tikkanen MJ
J Lab Clin Med; 1992 Jul; 120(1):103-10. PubMed ID: 1613316
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of the effectiveness of the HMG-CoA-reductase inhibitors pravastatin versus colestyramine in hypercholesteremia].
Schwartzkopff W; Bimmermann A; Schleicher J
Arzneimittelforschung; 1990 Dec; 40(12):1322-7. PubMed ID: 2128866
[TBL] [Abstract][Full Text] [Related]
13. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.
Nishizawa Y; Shoji T; Emoto M; Kawasaki K; Konishi T; Tabata T; Inoue T; Morii H
Clin Nephrol; 1995 Apr; 43(4):268-77. PubMed ID: 7606882
[TBL] [Abstract][Full Text] [Related]
14. Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A.
Superko HR; Berneis KK; Williams PT; Rizzo M; Wood PD
Am J Cardiol; 2005 Nov; 96(9):1266-72. PubMed ID: 16253595
[TBL] [Abstract][Full Text] [Related]
15. Effects of pravastatin on lipid transfer protein and lecithin cholesterol acyltransferase in heterozygous familial hypercholesterolemia.
Fusegawa Y; Tada H; Oguma T; Shiina Y; Moriguchi EH; Tanabe T; Tamachi H; Tomoda H; Goto Y
Tokai J Exp Clin Med; 1993 Dec; 18(3-6):81-6. PubMed ID: 7701533
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteins.
Richter WO; Jacob BG; Schwandt P
Int J Tissue React; 1991; 13(2):107-10. PubMed ID: 1955291
[TBL] [Abstract][Full Text] [Related]
17. Changes in plasma lipids, lipoproteins and apolipoproteins in hypercholesterolaemic patients treated with pravastatin.
Lijnen P; Celis H; Desager JP; Fagard R
J Hum Hypertens; 1995 Jul; 9(7):557-64. PubMed ID: 7562885
[TBL] [Abstract][Full Text] [Related]
18. Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin.
Rodenburg J; Vissers MN; Wiegman A; Miller ER; Ridker PM; Witztum JL; Kastelein JJ; Tsimikas S
J Am Coll Cardiol; 2006 May; 47(9):1803-10. PubMed ID: 16682304
[TBL] [Abstract][Full Text] [Related]
19. Influence of cholesterol-lowering on plasma membrane lipids and function.
Lijnen P; Echevaría-Vázquez D; Petrov V
Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the therapeutic efficacy of pravastatin in monothereapy and in association with gemfibrozil in hypercholesterolemia associated with moderate hyperglyceridemia].
Napoli C; Lepore S; Ambrosio G; Chiariello M
Cardiologia; 1992 Nov; 37(11):761-8. PubMed ID: 1298545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
